Patents by Inventor Lily Bazak

Lily Bazak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160216281
    Abstract: Novel splice variants, amino acid sequences and nucleotide sequences thereof, and methods of using same.
    Type: Application
    Filed: April 11, 2016
    Publication date: July 28, 2016
    Inventors: Osnat Sella-Tavor, Sarah Pollock, Gad S. Cojocaru, Amit Novik, Lily Bazak, Elena Tsypkin, Shira Wallach, Shirley Sameah-Greenwald
  • Patent number: 9347952
    Abstract: Novel splice variants, amino acid sequences and nucleotide sequences thereof, and methods of using same.
    Type: Grant
    Filed: January 12, 2015
    Date of Patent: May 24, 2016
    Assignee: Compugen Ltd.
    Inventors: Osnat Sella-Tavor, Sarah Pollock, Gad S. Cojocaru, Amit Novik, Lily Bazak, Elena Tsypkin, Shira Wallach, Shirley Sameah-Greenwald
  • Publication number: 20150132318
    Abstract: Novel splice variants, amino acid sequences and nucleotide sequences thereof, and methods of using same.
    Type: Application
    Filed: January 12, 2015
    Publication date: May 14, 2015
    Inventors: Osnat Sella-Tavor, Sarah Pollock, Gad S. Cojocaru, Amit Novik, Lily Bazak, Elena Tsypkin, Shira Wallach, Shirley Sameah-Greenwald
  • Publication number: 20140037549
    Abstract: The present invention discloses markers useful in predicting the responsiveness of a subject having, or at risk of developing rheumatoid arthritis (RA) to treatment with anti-TNF agents. Particularly, the present invention discloses the allelic configuration of the CD6 gene and/or the STXBP6 gene which is indicative of the degree of responsiveness to anti-TNF? treatment of RA.
    Type: Application
    Filed: February 12, 2012
    Publication date: February 6, 2014
    Applicant: COMPUGEN LTD.
    Inventors: Akiva Pinchas, Sarit Edelheit-Flohr, Lily Bazak, Zurit Levine, Amir Toporik, Ofer Levy, Tomer Zekharya, Assaf Wool
  • Patent number: 7842459
    Abstract: Novel splice variant nucleic acid sequences. The novel splice variants and their nucleic acid sequences according to the present invention may optionally be used for diagnosis of a variant-detectable disease as described herein.
    Type: Grant
    Filed: January 27, 2005
    Date of Patent: November 30, 2010
    Assignee: Compugen Ltd.
    Inventors: Michal Ayalon-Soffer, Sarah Pollock, Ronen Shemesh, Rotem Sorek, Zurit Levine, Zipi Shaqed, Amir Toporik, Gad S. Cojocaru, Dvir Dahary, Guy Kol, Pinchas Akiva, Amit Novik, Sergey Nemzer, Alexander Diber, Maxim Shklar, Osnat Sella-Tavor, Lily Bazak, Ariel Farkash, Yossi Cohen
  • Publication number: 20100189652
    Abstract: Novel splice variants as diagnostic markers, preferably membrane-bound. The novel variants according to the present invention may optionally be used for diagnosis of Marker-detectable disease as described herein, optionally through immunohistochemistry.
    Type: Application
    Filed: April 12, 2010
    Publication date: July 29, 2010
    Inventors: SARAH POLLOCK, ANAT COHEN-DAYAG, OSNAT SELLA-TAVOR, SHIRLEY SAMEAH-GREENWALD, SHIRA WALACH, LILY BAZAK
  • Publication number: 20100184021
    Abstract: The present invention relates to diagnostic markers comprising novel splice variants of known proteins and polynucleotides encoding same, useful in the qualitative and/or quantitative detection of various diseases and/or pathological conditions in a subject, and to the use of known proteins and polynucleotides encoding same for diagnosis. Particularly, the invention relates to the diagnosis of a disease in a sample of body fluid or secretion obtained from the subject, and to the diagnosis of cancer.
    Type: Application
    Filed: January 16, 2007
    Publication date: July 22, 2010
    Inventors: Osnat Sella-Tavor, Sarah Pollack, Lily Bazak, Elena Tsypkin, Dan Sztybel, Shirley Sameah-Greenwald
  • Publication number: 20100184839
    Abstract: The invention relates to the identification of allelic polymorphism in a diabetes associated gene, particularly in a gene encoding phosphofructokinase (PFK) and use thereof for diagnosing diabetes predisposition and state and for predicting the response to a therapeutic agent.
    Type: Application
    Filed: April 30, 2008
    Publication date: July 22, 2010
    Inventors: Avishay Vaknin, Pini Akiva, Sarah Pollock, Lily Bazak, Erez Levanon, Tomer Zekharya, Alex Golubev, Gady Cojocaru, Liat Dassa, Sarit Edelheit-Flohr, Ronen Shemesh, Anat Amir, Yossi Cohen
  • Patent number: 7741433
    Abstract: Novel splice variants as diagnostic markers, preferably membrane-bound. The novel variants according to the present invention may optionally be used for diagnosis of Marker-detectable disease as described herein, optionally through immunohistochemistry.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: June 22, 2010
    Assignee: Compugen Ltd.
    Inventors: Sarah Pollock, Anat Cohen-Dayag, Osnat Sella-Tavor, Shirley Sameah-Greenwald, Shira Walach, Lily Bazak
  • Publication number: 20100120022
    Abstract: Novel splice variant nucleic acid sequences. The novel splice variants and their nucleic acid sequences according to the present invention may optionally be used for diagnosis of a variant-detectable disease as described herein.
    Type: Application
    Filed: January 27, 2005
    Publication date: May 13, 2010
    Inventors: Michal Ayalon-Soffer, Sarah Pollock, Ronen Shemesh, Rotem Sorek, Zurit Levine, Zipi Shaqed, Amir Toporik, Gad S. Cojocaru, Dvir Dahary, Guy Kol, Pinchas Akiva, Amit Novik, Sergey Nemzer, Alexander Diber, Maxim Shklar, Osnat Sella-Tavor, Lily Bazak, Ariel Farkash, Yossi Cohen
  • Publication number: 20090275021
    Abstract: Novel splice variants, amino acid sequences and nucleotide sequences thereof, and methods of using same.
    Type: Application
    Filed: November 27, 2006
    Publication date: November 5, 2009
    Inventors: Osnat Sella-Tavor, Sarah Pollock, Lily Bazak, Elena Tsypkin, Shira Wallach, Eve Montia, Shirley Sameah-Greenwald
  • Publication number: 20090215042
    Abstract: Novel splice variants, amino acid sequences and nucleotide sequences thereof, and methods of using same.
    Type: Application
    Filed: June 8, 2006
    Publication date: August 27, 2009
    Inventors: Osnat Sella-Tavor, Sarah Pollock, Gad S. Cojocaru, Amit Novik, Lily Bazak, Elena Tsypkin, Shira Wallach, Shirley Sameah-Greenwald
  • Publication number: 20090202991
    Abstract: Novel splice variants as diagnostic markers, preferably membrane-bound. The novel variants according to the present invention may optionally be used for diagnosis of Marker-detectable disease as described herein, optionally through immunohistochemistry.
    Type: Application
    Filed: October 30, 2007
    Publication date: August 13, 2009
    Inventors: Sarah POLLOCK, Anat Cohen-Dayag, Osnat Sella-Tavor, Shirley Sameah-Greenwald, Shira Walach, Lily Bazak
  • Publication number: 20090176217
    Abstract: Novel splice variants, amino acid sequences and nucleotide sequences thereof, and methods of using same.
    Type: Application
    Filed: October 3, 2006
    Publication date: July 9, 2009
    Inventors: Osnat Sella-Tavor, Sarah Pollock, Gad S. Cojocaru, Amit Novik, Lily Bazak, Elena Tsypkin, Shira Wallach, Shirley Sameah-Greenwald
  • Patent number: 7488813
    Abstract: Novel splice variants as diagnostic markers, preferably membrane-bound. The novel variants according to the present invention may optionally be used for diagnosis of Marker-detectable disease as described herein, optionally through immunohistochemistry.
    Type: Grant
    Filed: February 24, 2006
    Date of Patent: February 10, 2009
    Assignee: Compugen, Ltd.
    Inventors: Sarah Pollock, Anat Cohen-Dayag, Osnat Sella-Tavor, Shirley Sameah-Greenwald, Shira Walach, Lily Bazak
  • Publication number: 20060257896
    Abstract: Novel splice variants as diagnostic markers, preferably membrane-bound. The novel variants according to the present invention may optionally be used for diagnosis of Marker-detectable disease as described herein, optionally through immunohistochemistry.
    Type: Application
    Filed: February 24, 2006
    Publication date: November 16, 2006
    Applicant: Compugen Ltd.
    Inventors: Sarah Pollock, Anat Cohen-Dayag, Osnat Sella-Tavor, Shirley Sameah-Greenwald, Shira Walach, Lily Bazak